Yuson, Gilbert S.

HRN: 29-30-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/09/2026
07/16/2026
IV
Q8h
Q8h
INTESTINAL AMOEBIASIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines